Private company
Genome Therapeutics Corporation
Defunct American biotech company1
Genome Therapeutics Corp. was an early biotech company. It was founded in 1961 by Orrie M. Friedman under the name Collaborative Research Inc. Under the leadership of Helen Donis-Keller and using internal funds, the company produced one of the first linkage maps of the whole human genome in the mid-1980s. The name was later changed its name to Genome Therapeutics.3 It is headquartered in Waltham, Massachusetts.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 20, 2026.
Overview
- IndustryPharmaceutical Preparations1
- HeadquartersWaltham, Massachusetts1
- Incorporated inMA4
- Business address1000 Winter Street, Suite 2200, Waltham, Ma 024514
See how the biggest companies compare on our leaderboards
Genome Therapeutics Corp. was an early biotech company. It was founded in 1961 by Orrie M. Friedman under the name Collaborative Research Inc. Under the leadership of Helen Donis-Keller and using internal funds, the company produced one of the first linkage maps of the whole human genome in the mid-1980s.3
Leadership
Who has led Genome Therapeutics Corporation, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerSteven M. Rauscher Mar 16, 2006 to Mar 13, 20085
- PresidentSteven M. Rauscher Mar 16, 2006 to Mar 13, 20085
- Chief financial officerPhilippe M. Maitre May 24, 2006 to Mar 13, 20086
Board members and other officers (13)
- SVP, Sales & MarketingMark A. Glickman Jul 30, 2008 to Jul 30, 20087
- EVP Corporate Dev & OperationsDominick Colangelo Mar 16, 2006 to Mar 13, 20088
- Board memberJohn R. Leone Dec 10, 2007 to Jun 13, 20089
- Board memberGary Patou Jan 4, 2006 to Jun 13, 200810
- Board memberLuke Evnin Jan 4, 2006 to Jan 9, 200611
- Board memberSteven M. Rauscher Mar 16, 2006 to Mar 13, 20085
- Board memberDavid K. Stone May 24, 2006 to Jun 13, 200812
- Board memberJohn E. Voris Jun 12, 2006 to Jun 8, 200713
- Board memberNorbert G. Riedel Jun 12, 2006 to Jun 13, 200814
- Board memberPamela J. Kirby Jun 12, 2006 to Jun 12, 200615
- Board memberWilliam R. Mattson Jr. Jun 12, 2006 to Jun 13, 200816
- Board memberWilliam S. Reardon Jun 12, 2006 to Jun 13, 200817
- Board memberWalter Flamenbaum Md. Dec 8, 2006 to Jun 8, 200718
Former names
- GENOME THERAPEUTICS CORPJul 21, 1995 to Apr 8, 20044
Timeline
- Mar 16, 2006New chief executive Steven M. Rauscher becomes CEO5
SEC filer profile
How Genome Therapeutics Corporation is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGAROSCIENT PHARMACEUTICALS CORP2
- CIK0000356830
- Employer ID (EIN)04-22974842
- Incorporated inMassachusetts2
- Fiscal year endsDecember 312
- Industry code (SIC)2834 Pharmaceutical Preparations2
- Business address1000 Winter Street, Suite 2200, Waltham, MA 024512
- Phone78139823002
- On EDGAR sinceApr 11, 19952
- Filings745 in all: 4 (250), 8-K (151), 10-Q (42), SC 13G/A (32), 3 (24), SC 13G (24), 425 (18), S-3/A (17)2
All 53 form types
S-8 (15), 424B3 (12), S-3 (12), 10-K (11), DEF 14A (11), 10-K/A (9), POS AM (8), S-4/A (8), UPLOAD (8), 8-K/A (7), CORRESP (7), 10-Q/A (5), 4/A (5), ARS (5), SC TO-I/A (5), 424B4 (4), 424B5 (4), EFFECT (4), PRE 14A (4), 10-K405 (3), DEFS14A (3), REGDEX (3), S-4 (3), 424B2 (2), 5 (2), DEFA14A (2), FWP (2), S-1 (2), S-1/A (2), S-3MEF (2), SC 13D/A (2), SC TO-I (2), 10-12G/A (1), 10-C (1), 10-K405/A (1), 10-QT (1), 25-NSE (1), 3/A (1), 424B7 (1), AW (1), DEL AM (1), NT 10-Q (1), POS EX (1), RW (1), S-1MEF (1)
- Latest filingsAnnual report (10-K) Mar 25, 2009
Quarterly report (10-Q) Nov 10, 2008
Proxy statement (DEF 14A) Apr 22, 2008
Latest 8-K (8-K) Jul 13, 2009
Links
- WikipediaGenome Therapeutics Corporation
- WikidataQ5533484
- SEC EDGARCIK 356830
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARJohn R. Leone, Board member
- 10SEC EDGARGary Patou, Board member
- 11SEC EDGARLuke Evnin, Board member
- 12SEC EDGARDavid K. Stone, Board member
- 13SEC EDGARJohn E. Voris, Board member
- 14SEC EDGARNorbert G. Riedel, Board member
- 15SEC EDGARPamela J. Kirby, Board member
- 16SEC EDGARWilliam R. Mattson Jr., Board member
- 17SEC EDGARWilliam S. Reardon, Board member
- 18SEC EDGARWalter Flamenbaum Md., Board member